U.S. Food and Staples Retail Stock News

Earlier this week, Cleveland-Cliffs faced softer sentiment after analysts trimmed their outlook on U.S. steel pricing and insiders disclosed US$2.90 million in recent share sales without any offsetting purchases. The combination of a more cautious analyst stance, insider selling, and consecutive days of underperformance versus the broader market has sharpened investor focus on how resilient Cleveland-Cliffs' tariff-supported and auto-heavy business model really is. We’ll now examine how the...

On June 17, 2026, CONMED Corporation announced that John E. Gallagher will become Executive Vice President and Chief Financial Officer, as well as principal financial and accounting officer, effective July 15, 2026. Gallagher’s broad background across healthcare and industrial companies, including senior finance roles at Certara, Cue Health, and Becton Dickinson, positions him to influence CONMED’s capital allocation, reporting quality, and investor communication. We’ll now examine how...

National Fuel Gas (NFG) is back in focus after its Seneca Resources segment agreed with Evolution Well Services to roll out electric fracturing technology across its Appalachian basin operations, tying efficiency goals to environmental considerations. See our latest analysis for National Fuel Gas. The recent electric fracturing agreement lands at a time when National Fuel Gas’s share price has eased, with the 30 day share price return down 4.17% and the 90 day share price return down 19.71%,...

Earlier this week, Bunge Global SA was added to the Zacks Rank #1 (Strong Buy) list after analysts lifted their current-year earnings consensus estimate by 12.3% over the past 60 days. This upgrade highlights a meaningful shift in analyst expectations, suggesting that recent earnings revisions may be reshaping how the market views Bunge’s earnings power and business momentum. We’ll now consider how Bunge’s addition to the Zacks Rank #1 list, driven by rising earnings estimates, affects its...

Core & Main (CNM) has launched a $750 million senior notes offering due 2034, a move that reshapes its capital structure and may influence how investors view its debt profile and growth plans. See our latest analysis for Core & Main. Core & Main’s latest share price of $48.26 comes after a 2.40% 1 day share price return and a year to date share price return that is down 9.64%. The 3 year total shareholder return of 55.88% contrasts with a 1 year total shareholder return that is down 18.62%,...

Alliance Resource Partners recently moved to expand its mineral interests through a major royalty acquisition, aiming to enhance income from high-grade metallurgical coal amid a broader decline in U.S. coal production and usage. This combination of increased royalty exposure and focus on higher-grade coal stands out as a way the partnership is seeking to diversify within a shrinking domestic coal landscape. We’ll now examine how this mineral royalty acquisition shapes Alliance Resource...

Earlier in June 2026, Knowles expanded its portfolio of high-performance film and ceramic high-energy pulse discharge capacitors, highlighting custom, tightly controlled energy delivery solutions for applications spanning neuromodulation, industrial lasers, downhole energy exploration, medical equipment and advanced energy research, supported by investments in testing, process controls and application-specific design. This push further complements Knowles’ broader transformation toward...

With the Federal Reserve, inflation data, jobs reports, and earnings headlines all shaping expectations, many investors are looking at quality dividend stocks as a potential anchor for their portfolios. The Quality Dividend Stocks screener focuses on established companies with relatively strong dividend scores and solid balance sheets, which some investors see as helpful when conditions feel uncertain. This article explains how the latest macro and corporate catalysts may interact with that...

Indivior Pharmaceuticals (INDV) continues to attract attention after its recent share price move, with the stock last closing at $41.29. See our latest analysis for Indivior Pharmaceuticals. Over the past year, Indivior Pharmaceuticals has shifted from short-term volatility to stronger momentum, with a 90-day share price return of 42.53% and a 1-year total shareholder return of 201.61% pointing to a significantly improved market perception of its prospects and risks. If this kind of momentum...

Wayfair Inc. recently announced plans to open a new approximately 135,000-square-foot large-format retail store in 2027 at Nassau Park Pavilion in Princeton, New Jersey, expanding its omnichannel presence across New Jersey, New York and Pennsylvania with same-day take-home options, fast delivery for larger items and free design services. This move extends Wayfair’s growing physical-store network alongside locations in Illinois, Georgia and Ohio, highlighting how the company is pairing...

CarMax (KMX) has opened its 2027 financial year with Q1 revenue of about US$8.5b and basic EPS of US$1.31, setting a clear benchmark for how the rest of the year might unfold. Over the past year, the company has seen quarterly revenue move from about US$8.0b in Q1 2026 to US$8.5b in Q1 2027, while basic EPS shifted from US$1.38 to US$1.31. This gives investors a clean year-on-year read on top line scale and per share earnings. With net income of US$185.6m and trailing 12 month EPS of US$1.54,...

Nano-X Imaging (NNOX) has opened Q1 2026 with total revenue of US$4.3 million and a basic EPS loss of US$0.20, setting the tone for another period where investors are weighing growth against ongoing losses. Over the past year, the company has seen quarterly revenue move from US$2.8 million in Q1 2025 to US$4.3 million in Q1 2026. During the same period, basic EPS has ranged from a loss of US$0.50 in Q4 2025 to a loss of roughly US$0.20 in the latest quarter, keeping the focus squarely on how...

Recent Share Performance Context for Lamb Weston Holdings Lamb Weston Holdings (LW) has drawn attention after a period where the stock declined about 13% over the past year, even as returns over the past month and past 3 months have been positive. This mixed performance profile has some investors reassessing how the frozen potato producer’s current valuation aligns with its recent financial results, including its reported revenue of about $6.5b and net income of roughly $300.3m. See our...

SoftBank CEO Masayoshi Son has outlined a long term vision for Arm Holdings, suggesting its value could rise significantly as it becomes a core supplier for AI infrastructure. Arm is shifting its business model from primarily licensing chip designs to selling complete CPUs, a move that echoes the approach used by some large GPU suppliers in AI. New analyst work from several banks points to Arm potentially gaining meaningful share in CPUs for agentic AI data centers by 2030, which would...

GameStop (NYSE:GME) CEO Ryan Cohen has asked the board to cancel a US$35b performance award. The decision is tied to Cohen’s plan to pursue an acquisition of eBay, marking a shift beyond GameStop’s core retail focus. eBay’s board has rejected the initial proposal, and Cohen has signaled an intention to take the offer directly to eBay shareholders. GameStop, long associated with video game retail, is now at the center of a much broader story. By linking the withdrawal of a US$35b performance...

Inflation is front and center again, with the latest CPI report showing a 4.2% annual rise and energy costs jumping sharply. That mix can squeeze some companies while giving others more pricing power or demand resilience. For investors, the key question is which stocks are directly exposed to these moves in consumer prices and energy, and how that exposure could shape earnings risk or opportunity. This article pulls out three stocks tied to the recent CPI and energy spike, highlighting one...

Balchem stock performance snapshot and recent returns Balchem (BCPC) has drawn fresh attention after recent price moves, with the stock last closing at $169.23 and showing gains over the past week, month and past 3 months. For context, Balchem reports annual revenue of $1.06b and net income of $158.08m, reflecting its role across human and animal nutrition and specialty products, primarily in the United States. See our latest analysis for Balchem. Zooming out, Balchem’s share price return of...

Fermi (FRMI) is back in focus after a 7 day stock rally coinciding with fresh progress on Project Matador, including a new gas turbine agreement and recent testimony on its data center water use plans. See our latest analysis for Fermi. Against a backdrop of heated governance disputes and fresh Project Matador milestones, Fermi’s share price has seen a 1-day share price return of 10.14% and a 30-day share price return of 36.86%. The year to date share price return is broadly flat. If the...

Carlyle Group (CG) has introduced a new climate risk framework during London Climate Action Week, tying asset valuations to resilience against severe weather and using insurance partnerships to reward portfolio companies that invest in protective upgrades. See our latest analysis for Carlyle Group. Despite the climate framework announcement, Carlyle Group’s recent share price momentum has been weak, with the stock at US$41.90 and the year to date share price return down 31.15%. However, the 3...

McKesson is investing in a new highly automated regional pharmaceutical distribution facility in Moore, Oklahoma. The project is intended to expand capacity and modernize the company’s distribution network across Oklahoma, Texas, and nearby states. The move is aimed at improving supply chain reliability and efficiency for pharmacies, hospitals, and health systems in the region. For investors tracking McKesson (NYSE:MCK), this new facility comes as the stock trades around $763.81, with a...

If you are wondering whether Edwards Lifesciences stock offers good value at its current price, the key question is how that price compares with what the business may reasonably be worth. The stock most recently closed at US$89.72, with returns of 2.7% over the past week, 2.5% over the last month, 5.1% year to date, and 16.3% over the past year. However, 3 year and 5 year returns are lower, at a decline of 2.5% and 14.4% respectively. Recent coverage around Edwards Lifesciences has focused...

With inflation trends, central bank decisions and bond yields all pulling markets in different directions, many investors are looking for a steadier core for their portfolios. The Low-Risk Leaders screener focuses on companies with strong balance sheets and some of the lowest risk scores in the model, offering a way to stay invested while aiming to keep overall volatility in check. As growth signals, oil prices and housing data continue to shape sentiment, this kind of resilient foundation...

Deere (NYSE:DE) has raised its full-year net income guidance. The company has also announced a new share repurchase program. Management is addressing margin pressures through operational efficiencies. Deere is benefiting from reduced tariffs alongside the adoption of new technologies. Deere, the farm and construction equipment maker, is updating its outlook at a time when the sector is working through margin pressures and changing demand patterns. The company operates across agriculture,...

ESOP linked shelf registration puts potential dilution in focus C3.ai (AI) has filed a shelf registration to offer up to US$114.85 million of Class A common stock tied to an employee stock ownership plan, putting potential future dilution and incentive alignment on investor radar. See our latest analysis for C3.ai. The shelf registration arrives after a sharp 1 day share price decline of 6.12% and a 7 day share price return down 15.05%, while the 90 day share price return is up 12.76% but the...